It should be noted that slightly higher detection rates with abdominal CT in HER2+ patients have also been reported, however, while this result suggests that additional staging investigations should be warranted for this subgroup of breast cancer, these findings were not stratified by clinical stage [16]. This evidence concerns the gene ERBB2 and breast carcinoma.